Microsatellite instability did not predict individual survival in sporadic stage II and III rectal cancer patients

Oncology

Volumn 72, Issue 1-2, 2007, Pages 82-88

  Meng, Wen Jian ^a   Sun, Xiao Feng ^b   Tian, Chao ^a   Wang, Ling ^a   Yu, Yong Yang ^a   Zhou, Bing ^a   Gu, Jun ^a   Xia, Qing Jie ^a   Li, Yuan ^a   Wang, Rong ^a   Zheng, Xue Lian ^a   Zhou, Zong Guang ^a  

^a SICHUAN UNIVERSITY   (China)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Microsatellite instability; Prognosis; Sporadic rectal cancer; Tumor stage

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; DNA;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEALTH CARE ORGANIZATION; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; MICROSATELLITE INSTABILITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECTUM CANCER;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHINA; FEMALE; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECTAL NEOPLASMS;

EID: 37049036566     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111107     Document Type: Article

References (29)

1. Chapuis PH, Dent OF, Fisher R, Newland RC, Pheils MT, Smyth E, Colquhoun K: A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 1985;72:698-702.
2. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Staudt LM: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002;346:1937-1947.
3. Peltomäki P: Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet 2001;10:735-740.
4. Popat S, Hubner R, Houlston RS: Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 2005;23:609-618.
5. Parc Y, Gueroult S, Mourra N, Serfaty L, Flejou JF, Tiret E, Parc, R: Prognostic significance of microsatellite instability determined by immunohistochemical staining of MSH2 and MLH1 in sporadic T3N0M0 colon cancer. Gut 2004;53:371-375.
6. Samowitz WS, Curtin K, Ma KN, Schaffer D, Coleman LW, Leppert M, Slattery ML: Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev 2001;10:917-923.
7. Gryfe R, Kim H, Hsieh ET, Aronson MD, Holowaty EJ, Bull SB, Redston M, Gallinger S: Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000;342:69-77.
8. Emterling A, Wallin Å, Arbman G, Sun XF: Clinicopathological significance of microsatellite instability and mutated RIZ in colorectal cancer. Ann Oncol 2004;15:242-246.
9. Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R, Shepherd LE, Tu D, Redston M, Gallinger S: Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003;349:247-257.
10. Frattini M, Balestra D, Suardi S, Oggionni M, Alberici P, Radice P, Costa A, Daidone MG, Leo E, Pilotti S, Bertario L, Pierotti MA: Different genetic features associated with colon and rectal carcinogenesis. Clin Cancer Res 2004;10:4015-4021.
11. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow N: AJCC Cancer Staging Manual, ed 6. New York, Springer-Verlag, 2002.
12. Jass JR, Sobin LH: World Health Organization: International Histological Classification of Tumors: Histological Typing of Intestinal Tumors, ed 2. Berlin, Springer-Verlag, 1989.
13. Loukola A, Eklin K, Laiho P, Salovaara R, Kristo P, Jarvinen H, Mecklin JP, Launonen V, Aaltonen LA: Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). Cancer Res 2001;61:4545-4549.
14. Boland RC, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RM, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S: A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-5257.
15. Sanguinetti CJ, Dias Neto E, Simpson AJ: Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques 1994;17:914-921.
16. Nilbert M, Planck M, Fernebro E, Borg Å, Johnson A: Microsatellite instability is rare in rectal carcinomas and signifies hereditary cancer. Eur J Cancer 1999;35:942-945.
17. Morán A, Iniesta P, de Juan C, González-Quevedo R, Sánchez-Pernaute A, Díaz-Rubio E, Ramon y Cajal S, Torres A, Balibrea JL, Benito M: Stromelysin-1 promoter mutations impair gelatinase B activation in high microsatellite instability sporadic colorectal tumors. Cancer Res 2002;62:3855-3860.
18. JH Suh, SD Lim, JC Kim, SH Hong, GH Kang: Comparison of clinicopathologic characteristics and genetic alterations between microsatellite instability-positive and microsatellite instability-negative sporadic colorectal carcinomas in patients younger than 40 years old. Dis Colon Rectum 2002;45:219-228.
19. Boland CR, Sinicrope FA, Brenner DE, Carethers JM: Colorectal cancer prevention and treatment. Gastroenterology 2000;118:115-128.
20. Ikeda Y, Oda S, Abe T, Ohno S, Maehara Y, Sugimachi K: Features of microsatellite instability in colorectal cancer: comparison between colon and rectum. Oncology 2001;61:168-174.
21. Jernvall P, Makinen MJ, Karttunen TJ, Makela J, Vihko P: Microsatellite instability: impact on cancer progression in proximal and distal colorectal cancers. Eur J Cancer 1999;35:197-201.
22. Elsaleh H, Joseph D, Grieu F, Zeps N, Spry N, Iacopetta B: Association of tumor site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet 2000;355:1745-1750.
23. Chang EY, Dorsey PB, Johnson N, Lee R, Walts D, Johnson W, Anadiotis G, Kiser K, Frankhouse J: A prospective analysis of microsatellite instability as a molecular marker in colorectal cancer. Am J Surg 2006;191:646-651.
24. Jass JR: HNPCC and sporadic MSI-H colorectal cancer: a review of the morphological similarities and differences. Fam Cancer 2004;3:93-100.
25. Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, Majno P, Engerran L: Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996;224:509-520.
26. Marsoni S: Efficacy of adjuvant fluorouracil and leucovorin in stage B2 and C colon cancer. International Multicenter Pooled Analysis of Colon Cancer Trials Investigators. Semin Oncol 2001;28:14-19.
27. Haller DG: Defining the optimal therapy for rectal cancer. J Natl Cancer Inst 2000;92:361-362.
28. Watanabe Y, Koi M, Hemmi H, Hoshai H, Noda K: A change in microsatellite instability caused by cisplatin-based chemotherapy of ovarian cancer. Br J Cancer 2001;85:1064-1069.
29. Meyers M, Wagner MW, Mazurek A, Schmutte C, Fishel R, Boothman DA: DNA mismatch repair-dependent response to fluoropyrimidine-generated damage. J Biol Chem 2005;280:5516-5526.